ARKG vs JEPQ
ARK Genomic Revolution ETF vs JPMorgan Nasdaq Equity Premium Income ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
JEPQ—
JPMorgan Nasdaq Equity Premium Income ETF
Nasdaq-tilted equity income with options overlay.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | JEPQ |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | JPMorgan |
ARKG top holdings
Holdings data unavailable for ARKG.
JEPQ top holdings
Holdings data unavailable for JEPQ.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About JEPQ
JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) is Nasdaq-tilted equity income with options overlay.